Moderna will receive up to $54.3 million from the Coalition for Epidemic Preparedness Innovations to fund continued ...

In a statement accompanying the announcement of Risch to the cancer panel, HHS Secretary Robert F. Kennedy Jr. — himself a ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development.

Cancer has long been medicine’s most elusive target, but a wave of new research suggests scientists may finally be closing in ...

Tattoos have gained widespread popularity, with nearly one in three Americans having at least one. But beneath the colorful designs lurks a hidden journey. According to a new study, tattoo ink doesn’t ...

Non-profit arm of the de-extinction company secures an additional $50 million, expands global projects and partnerships, and releases its inaugural Impact Report detailing progress in the fight ...

Last Friday, Stanford Medicine confirmed that the mRNA-based COVID-19 vaccine can cause myocarditis. In a new study, the ...

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p ...